Excia T Cementless EBRA Study

Non-Interventional Post Market Clinical Follow-up Study Excia T® Cementless EBRA Study

In this Post Market Clinical Follow-up Study (PMCF Study), the short-term clinical and radiological results of the cementless Excia T® prosthesis in routine clinical use shall be assessed and the migration taking place in the first 24 months evaluated.

Inclusion Criteria:

• Written patient consent to study participation
• Age > 18 years
• Indication for primary THA with cementless Excia T® stem

Exclusion Criteria:

• Pregnancy
• THA after fracture
• Rheumatoid arthritis
• Systemic disorders, treated with Cortisone or other pharmaceuticals, potentially compromising the bone quality
• Patient physically or mentally not able to follow the postoperative examination routine